[Endothelial dysfunction in patients with primary hypertension and hyperhomocysteinemia]

Area of Science:

• Cardiovascular Science
• Endothelial Biology
• Hypertension Research

Background:

• Endothelial dysfunction is a key factor in cardiovascular diseases like hypertension.
• Impaired vascular expansion, atherosclerosis, and thrombosis are linked to endothelial dysfunction.
• Hyperhomocysteinemia is a significant factor damaging the endothelium, alongside traditional risk factors.

Purpose of the Study:

• To elucidate the mechanisms by which hyperhomocysteinemia contributes to endothelial dysfunction and hypertension.
• To investigate the biochemical and cellular effects of elevated homocysteine on the vascular wall.
• To understand the role of hyperhomocysteinemia in vascular remodeling and target organ damage.

Main Methods:

• The study reviews existing literature on hyperhomocysteinemia and endothelial function.
• Biochemical pathways affected by homocysteine, including oxidative stress and vasodilator synthesis, are examined.
• Cellular effects such as endothelial cell division inhibition and myocyte proliferation are discussed.

Main Results:

• Hyperhomocysteinemia induces oxidative stress by promoting oxygen radical formation.
• It impairs vasodilator factor biosynthesis and endothelial cell division.
• Homocysteine modifies LDL/HDL, promotes inflammation, and disrupts coagulation/fibrinolysis.

Conclusions:

• Hyperhomocysteinemia-induced endothelial damage leads to vascular remodeling, reduced flexibility, and diastolic dysfunction.
• These vascular changes contribute to increased blood pressure and the progression of hypertension.
• Elevated homocysteine levels exacerbate target organ damage in hypertensive patients.